<![CDATA[Celgene Corporation and Acceleron Pharma Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=32934>Wed, 29 Apr 2026 22:47:03 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Celgene Corporation and Acceleron Pharma Announce Submission of Luspatercept Marketing Authorization Application to the European Medicines Agency (EMA) for MDS and Beta-Thalassemia]]>https://www.newswire.co.kr/newsRead.php?no=887305Mon, 29 Apr 2019 09:45:00 +0900